Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasis.

Rai G, Sayed AA, Lea WA, Luecke HF, Chakrapani H, Prast-Nielsen S, Jadhav A, Leister W, Shen M, Inglese J, Austin CP, Keefer L, Arnér ES, Simeonov A, Maloney DJ, Williams DL, Thomas CJ.

J Med Chem. 2009 Oct 22;52(20):6474-83. doi: 10.1021/jm901021k.

2.

Macromolecular bases of antischistosomal therapy.

Angelucci F, Miele AE, Boumis G, Brunori M, Dimastrogiovanni D, Bellelli A.

Curr Top Med Chem. 2011;11(16):2012-28. Review.

PMID:
21619508
3.

Thioredoxin glutathione reductase: its role in redox biology and potential as a target for drugs against neglected diseases.

Prast-Nielsen S, Huang HH, Williams DL.

Biochim Biophys Acta. 2011 Dec;1810(12):1262-71. doi: 10.1016/j.bbagen.2011.06.024. Epub 2011 Jul 14. Review.

4.

Toward organometallic antischistosomal drug candidates.

Hess J, Keiser J, Gasser G.

Future Med Chem. 2015;7(6):821-30. doi: 10.4155/fmc.15.22. Review.

PMID:
25996072
5.

Schistosomiasis control: praziquantel forever?

Cioli D, Pica-Mattoccia L, Basso A, Guidi A.

Mol Biochem Parasitol. 2014 Jun;195(1):23-9. doi: 10.1016/j.molbiopara.2014.06.002. Epub 2014 Jun 21. Review.

PMID:
24955523
6.

Thioredoxin glutathione reductase-dependent redox networks in platyhelminth parasites.

Williams DL, Bonilla M, Gladyshev VN, Salinas G.

Antioxid Redox Signal. 2013 Sep 1;19(7):735-45. doi: 10.1089/ars.2012.4670. Epub 2012 Oct 3. Review.

7.

Schistosomiasis--a century searching for chemotherapeutic drugs.

Ribeiro-dos-Santos G, Verjovski-Almeida S, Leite LC.

Parasitol Res. 2006 Oct;99(5):505-21. Epub 2006 Apr 25. Review.

PMID:
16636847
8.

Natural products with antischistosomal activity.

de Moraes J.

Future Med Chem. 2015;7(6):801-20. doi: 10.4155/fmc.15.23. Review.

PMID:
25996071
9.

Experimentally promising antischistosomal drugs: a review of some drug candidates not reaching the clinical use.

Abdul-Ghani RA, Loutfy N, Hassan A.

Parasitol Res. 2009 Oct;105(4):899-906. doi: 10.1007/s00436-009-1546-2. Epub 2009 Jul 9. Review.

PMID:
19588166
10.

Praziquantel.

Cioli D, Pica-Mattoccia L.

Parasitol Res. 2003 Jun;90 Supp 1:S3-9. Epub 2002 Nov 22. Review.

PMID:
12811543
11.

[Progress in development of new antischistosomal drugs in recent years].

Xiao SH.

Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2010 Jun 30;28(3):218-25. Review. Chinese.

PMID:
20806509
12.

Current progress in the development and use of artemether for chemoprophylaxis of major human schistosome parasites.

Utzinger J, Xiao S, Keiser J, Chen M, Zheng J, Tanner M.

Curr Med Chem. 2001 Dec;8(15):1841-60. Review.

PMID:
11772354
13.

Drugs for the control of parasitic diseases: current status and development in schistosomiasis.

Fenwick A, Savioli L, Engels D, Robert Bergquist N, Todd MH.

Trends Parasitol. 2003 Nov;19(11):509-15. Review. No abstract available.

PMID:
14580962
14.

[Advances in research on antischistosomal drugs].

Qiu SJ, Xia CM.

Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2011 Jun;23(3):337-9. Review. Chinese.

PMID:
22164510
15.

New insight into praziquantel against various developmental stages of schistosomes.

Wu W, Wang W, Huang YX.

Parasitol Res. 2011 Dec;109(6):1501-7. doi: 10.1007/s00436-011-2670-3. Epub 2011 Oct 8. Review.

PMID:
21984370
16.

Schistosomiasis control: keep taking the tablets.

Hagan P, Appleton CC, Coles GC, Kusel JR, Tchuem-Tchuenté LA.

Trends Parasitol. 2004 Feb;20(2):92-7. Review.

PMID:
14747023
17.

The potential of artemether for the control of schistosomiasis.

Utzinger J, Xiao S, N'Goran EK, Bergquist R, Tanner M.

Int J Parasitol. 2001 Dec;31(14):1549-62. Review.

PMID:
11730781
18.

Drug resistance to schistosomicides and other anthelmintics of medical significance.

Brindley PJ.

Acta Trop. 1994 Mar;56(2-3):213-31. Review.

PMID:
8203304
19.

The redox biology of schistosome parasites and applications for drug development.

Huang HH, Rigouin C, Williams DL.

Curr Pharm Des. 2012;18(24):3595-611. Review.

20.

Re-positioning protein-kinase inhibitors against schistosomiasis.

Gelmedin V, Dissous C, Grevelding CG.

Future Med Chem. 2015;7(6):737-52. doi: 10.4155/fmc.15.31. Review.

PMID:
25996067
Items per page

Supplemental Content

Write to the Help Desk